Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Polycythemia Vera"" wg kryterium: Temat


Starter badań:

Tytuł :
Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm.
Autorzy :
Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yeon SH; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee MW; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Ryu H; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yun HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Kim SY; Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Jo DY; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Pokaż więcej
Źródło :
The Korean journal of internal medicine [Korean J Intern Med] 2021 Sep; Vol. 36 (5), pp. 1190-1203. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/epidemiology
Polycythemia Vera*/diagnosis
Polycythemia Vera*/epidemiology
Thrombosis*/epidemiology
Thrombosis*/etiology
Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; World Health Organization
Czasopismo naukowe
Tytuł :
Clinical outcomes of interferon therapy for polycythemia vera and essential thrombocythemia: a systematic review and meta-analysis.
Autorzy :
Gu W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China.; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.; CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.; Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
Yang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China.; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.; CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.; Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
Xiao Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China.; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.
Zhang L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China. .; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China. .; CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China. .; Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Sep; Vol. 114 (3), pp. 342-354. Date of Electronic Publication: 2021 Jun 06.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Interferons/*therapeutic use
Polycythemia Vera/*drug therapy
Thrombocythemia, Essential/*drug therapy
Biomarkers ; Cell Transformation, Neoplastic ; Disease Management ; Disease Progression ; Hematologic Tests ; Humans ; Interferons/pharmacology ; Polycythemia Vera/diagnosis ; Polycythemia Vera/etiology ; Prognosis ; Publication Bias ; Thrombocythemia, Essential/diagnosis ; Thrombocythemia, Essential/etiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
Autorzy :
Ming J; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Postdoctoral Research Programme of China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Liu W; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Wu H; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China. Electronic address: .
Li Y; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Yang E; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Wang Z; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: .
Xiao H; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Quan R; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Hu X; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Aug; Vol. 140, pp. 111767. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Journal Article
MeSH Terms :
Drugs, Chinese Herbal/*chemistry
Drugs, Chinese Herbal/*pharmacology
Polycythemia Vera/*drug therapy
Apoptosis/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Chromatography, High Pressure Liquid ; Humans ; Molecular Docking Simulation ; Phytochemicals/analysis ; Phytochemicals/pharmacology ; Polycythemia Vera/genetics ; Polycythemia Vera/metabolism ; Protein Interaction Maps ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł :
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms.
Autorzy :
Choi HS; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Hong J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Hwang SM; Department of Laboratory, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Lee JH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Ma Y; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Kim SA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Lee JY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Lee JO; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Bang SM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Oct; Vol. 100 (10), pp. 2567-2574. Date of Electronic Publication: 2021 Jul 30.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Hydroxyurea/*therapeutic use
Neoplasms, Second Primary/*etiology
Polycythemia Vera/*drug therapy
Thrombocythemia, Essential/*drug therapy
Adolescent ; Adult ; Antineoplastic Agents/adverse effects ; Aspirin/therapeutic use ; Child ; Female ; Fibrinolytic Agents/therapeutic use ; Follow-Up Studies ; Humans ; Hydroxyurea/adverse effects ; Leukemia/etiology ; Male ; Polycythemia Vera/complications ; Primary Myelofibrosis/etiology ; Thrombocythemia, Essential/complications ; Thromboembolism/drug therapy ; Thromboembolism/etiology ; Young Adult
Czasopismo naukowe
Tytuł :
Lemierre's Syndrome in an Elderly Female Patient with Polycythemia Vera: Does Polycythemia Vera Predispose to Lemierre's Syndrome?
Autorzy :
Kundal SV; Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Lee J; Department of Internal Medicine, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
Khalid M; Department of Cardiology, Maimonides Medical Center, Brooklyn, NY, USA.
Shani J; Department of Cardiology, Maimonides Medical Center, Brooklyn, NY, USA.
Hollander GM; Department of Cardiology, Maimonides Medical Center, Brooklyn, NY, USA.
Ping Z; Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Maung C; Department of Internal Medicine, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
Shetty VS; Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Pokaż więcej
Źródło :
The American journal of case reports [Am J Case Rep] 2021 Sep 29; Vol. 22, pp. e933587. Date of Electronic Publication: 2021 Sep 29.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Lemierre Syndrome*/complications
Lemierre Syndrome*/diagnosis
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Thrombophlebitis*
Aged ; Chest Pain ; Female ; Fusobacterium necrophorum ; Humans ; Jugular Veins/diagnostic imaging
Czasopismo naukowe
Tytuł :
Gaisbock's Syndrome: A Case Study.
Autorzy :
Rao S; Consultant Physician, Department of Internal Medicine, Department of Internal Medicine, Manipal Hospital, Bangalore, Karnataka.
Kalashetty M; Consultant Hematologist, Department of Hematology, Department of Internal Medicine, Manipal Hospital, Bangalore, Karnataka.
Venkateswarlu D; Resident (DNB), Department of Internal Medicine, Manipal Hospital, Bangalore, Karnataka.
Pokaż więcej
Źródło :
The Journal of the Association of Physicians of India [J Assoc Physicians India] 2021 Sep; Vol. 69 (9), pp. 11-12.
Typ publikacji :
Journal Article
MeSH Terms :
Hypertension*
Polycythemia*/etiology
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Aged ; Humans ; Male
Czasopismo naukowe
Tytuł :
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival.
Autorzy :
Abu-Zeinah G; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Krichevsky S; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Cruz T; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Hoberman G; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Jaber D; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Savage N; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Sosner C; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Ritchie EK; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Scandura JM; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
Silver RT; Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2592-2601. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Interferon-alpha/*therapeutic use
Polycythemia Vera/*mortality
Primary Myelofibrosis/*mortality
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Polycythemia Vera/drug therapy ; Polycythemia Vera/pathology ; Primary Myelofibrosis/prevention & control ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
Polycythemia Vera Associated with Pulmonary Hypertension and Diffuse Large B-Cell Lymphoma: A Case Report.
Autorzy :
Kameda S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Sera F; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Sato K; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kurashige M; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Higo S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Medical Therapeutics for Heart Failure, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Ohtani T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Tsuboi A; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hikoso S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yamaguchi O; Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Yamauchi-Takihara K; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Health and Counseling Center, Osaka University Graduate School of Medicine, Toyonaka, Osaka, Japan.
Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Pokaż więcej
Źródło :
The American journal of case reports [Am J Case Rep] 2021 Aug 26; Vol. 22, pp. e932956. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hypertension, Pulmonary*/etiology
Lymphoma, Large B-Cell, Diffuse*/complications
Myeloproliferative Disorders*
Polycythemia Vera*/complications
Polycythemia Vera*/genetics
Aged ; Bone Marrow ; Humans ; Male
Czasopismo naukowe
Tytuł :
[The relationship between symptom burden and hematologic responses after treatment with interferon/hydroxyurea in patients with polycythemia vera].
Autorzy :
Liu D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Xu ZF; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Qin TJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Qu SQ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Sun XJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Li B; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pan LJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Xiao ZJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Aug 14; Vol. 42 (8), pp. 635-641.
Typ publikacji :
Journal Article
MeSH Terms :
Hydroxyurea*
Polycythemia Vera*/drug therapy
Female ; Humans ; Interferon-alpha ; Male
Czasopismo naukowe
Tytuł :
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Autorzy :
Benevolo G; Division of Hematology, Città della Salute e della Scienza Hospital, Torino, Italy.
Elli EM; Hematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
Bartoletti D; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna Bologna, Italy.
Latagliata R; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Italy.
Heidel FH; Department of Hematology and Oncology, Friedrich-Schiller-University Medical Center, Jena, Germany.
Cavazzini F; Division of Hematology, University of Ferrara, Ferrara, Italy.
Bonifacio M; Department of Hematology, University of Verona, Verona, Italy.
Crugnola M; Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Binotto G; Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.
D'Addio A; Division of Hematology, Onco-Hematologic Department, AUSL della Romagna, Ravenna, Italy.
Tieghi A; Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Bergamaschi M; Department of Internal Medicine (DiMI), Clinic of Hematology, University of Genoa, Genova, Italy.
Caocci G; Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy.
Polverelli N; Unit of Blood Diseases and Stem Cell Transplantation, ASST Spedali Civili di Brescia, Brescia, Italy.
Bossi E; Hematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
Auteri G; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna Bologna, Italy.
Carmosino I; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
Catani L; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Cuneo A; Division of Hematology, University of Ferrara, Ferrara, Italy.
Krampera M; Department of Hematology, University of Verona, Verona, Italy.
Lanza F; Division of Hematology, Onco-Hematologic Department, AUSL della Romagna, Ravenna, Italy.
Lemoli RM; Department of Internal Medicine (DiMI), Clinic of Hematology, University of Genoa, Genova, Italy.; IRCCS Policlinico San Martino, Genova, Italy.
Vianelli N; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Breccia M; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
Palumbo GA; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy.
Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2021 Aug; Vol. 39 (3), pp. 409-418. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Body Mass Index*
Polycythemia Vera/*mortality
Primary Myelofibrosis/*mortality
Thrombosis/*mortality
Adult ; Aged ; Aged, 80 and over ; Comorbidity ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Polycythemia Vera/therapy ; Primary Myelofibrosis/therapy ; Retrospective Studies ; Risk Factors ; Thrombosis/therapy
Czasopismo naukowe
Tytuł :
[Analysis of Clinical Characteristics of JAK2 V617F and BCR-ABL Double-Mutant Myeloproliferative Neoplasms].
Autorzy :
Yan J; Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Ding YW; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Wang PY; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Wu YP; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Zhang HC; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China. E-mail: .
Liu LH; Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China. E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Oct; Vol. 29 (5), pp. 1540-1547.
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/genetics
Polycythemia Vera*
Thrombocythemia, Essential*
Adult ; Aged ; Aged, 80 and over ; Female ; Fusion Proteins, bcr-abl/genetics ; Humans ; Janus Kinase 2/genetics ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
A Comparison of Two Molecular Methods for Detecting CALR Mutations in Myeloproliferative Neoplasms.
Autorzy :
Chan TH
Wang YY
Chen CC
Huang WL
Lin IY
Er TK
Pokaż więcej
Źródło :
Clinical laboratory [Clin Lab] 2021 Sep 01; Vol. 67 (9).
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/genetics
Polycythemia Vera*
Calreticulin/genetics ; Humans ; Janus Kinase 2/genetics ; Mutation ; Receptors, Thrombopoietin/genetics
Czasopismo naukowe
Tytuł :
Prevalence of unexplained erythrocytosis and thrombocytosis - an NHANES analysis.
Autorzy :
Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alpert N; Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Taioli E; Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 2030-2033. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji :
Letter
MeSH Terms :
Polycythemia*/diagnosis
Polycythemia*/epidemiology
Polycythemia Vera*
Thrombocytosis*/diagnosis
Thrombocytosis*/epidemiology
Humans ; Nutrition Surveys ; Prevalence
Opinia redakcyjna
Tytuł :
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera.
Autorzy :
Krečak I; Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia. .
Morić Perić M; Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia.
Zekanović I; Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia.
Holik H; Department of Internal Medicine, 'Dr. Josip Benčević' General Hospital, Slavonski Brod, Croatia.; School of Medicine, University of Osijek, Osijek, Croatia.
Coha B; Department of Internal Medicine, 'Dr. Josip Benčević' General Hospital, Slavonski Brod, Croatia.
Gverić-Krečak V; Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia.
Lucijanić M; Department of Hematology, University Hospital Dubrava, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia.
Pokaż więcej
Źródło :
Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2021 Aug; Vol. 133 (15-16), pp. 808-815. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors*/therapeutic use
Polycythemia Vera*/drug therapy
Angiotensin Receptor Antagonists ; Glomerular Filtration Rate ; Humans ; Kidney ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Investigation of Laboratory and Clinical Feature in the Patients with Myeloproliferative Neoplasm Co-expression of BCR-ABL1 and JAK2 V617F].
Autorzy :
Yuan XG; Department of Hematology, Henan Xinhe Hospital, Xinyang 465000, Henan Province, China,Key Laboratory of Hematology, Zhengzhou Jinyu Clinical Laboratory Center, Zhengzhou 450016, Henan Province, China.
Wan RT; Department of Hematology, Henan Xinhe Hospital, Xinyang 465000, Henan Province, China.
Zhao XW; Key Laboratory of Hematology, Zhengzhou Jinyu Clinical Laboratory Center, Zhengzhou 450016, Henan Province, China,E-mail: .
Yang XZ; Department of Hematology, Puyang People's Hospital, Puyang 457000, Henan Province, China.
Xiao J; Department of Hematology, Puyang People's Hospital, Puyang 457000, Henan Province, China.
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Aug; Vol. 29 (4), pp. 1236-1241.
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/genetics
Polycythemia Vera*
Aged ; Fusion Proteins, bcr-abl/genetics ; Humans ; Janus Kinase 2/genetics ; Laboratories ; Mutation
Czasopismo naukowe
Tytuł :
Polycythaemia vera: molecular genetics, diagnostics and therapeutics.
Autorzy :
Putter JS; Medical Biomechanics Inc., North San Diego County, San Marcos, CA, USA.
Seghatchian J; International Consultancy in Innovative Manufacturing and Quality/Safety of Blood - Derived Bioproducts, London, UK.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jul; Vol. 116 (6), pp. 617-627. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Polycythemia Vera*/therapy
Thrombosis*
Humans ; Janus Kinase 2/genetics ; Molecular Biology ; Mutation
Czasopismo naukowe
Tytuł :
Cerebellar venous thrombosis mimicking a cerebellar tumor due to polycythemia vera: a case report.
Autorzy :
Wen H; Department of Neurology, Aerospace Center Hospital, Beijing, China.
Jin D; Department of Neurology, Aerospace Center Hospital, Beijing, China.
Chen Y; Department of Neurology, Aerospace Center Hospital, Beijing, China.
Cui B; Department of Radiology, Aerospace Center Hospital, Beijing, China.
Xiao T; Department of Neurology, Aerospace Center Hospital, Beijing, China. .
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2021 Jun 16; Vol. 21 (1), pp. 225. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Venous Thrombosis*/diagnosis
Venous Thrombosis*/etiology
Cerebellar Neoplasms ; Humans ; Janus Kinase 2/genetics ; Male ; Middle Aged ; Mutation/genetics
Czasopismo naukowe
Tytuł :
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
Autorzy :
Pimpinelli F; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
Marchesi F; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. .
Piaggio G; SAFU Unit, Department of Research and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Giannarelli D; Clinical Trial Center, Biostatistics and Bioinformatics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Papa E; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Falcucci P; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Spadea A; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Pontone M; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
Di Martino S; Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Laquintana V; Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
La Malfa A; Pharmacy Unit, Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.
Di Domenico EG; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
Di Bella O; Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.
Falzone G; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Ensoli F; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
Vujovic B; Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.
Morrone A; Scientific Direction, IRCCS San Gallicano Institute, Rome, Italy.
Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Mengarelli A; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Pokaż więcej
Źródło :
Journal of hematology & oncology [J Hematol Oncol] 2021 Jul 29; Vol. 14 (1), pp. 119. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji :
Letter
MeSH Terms :
Antibodies, Viral/*blood
COVID-19/*drug therapy
COVID-19 Vaccines/*administration & dosage
Polycythemia Vera/*immunology
Primary Myelofibrosis/*immunology
SARS-CoV-2/*drug effects
Thrombocythemia, Essential/*immunology
Aged ; Antibodies, Viral/immunology ; COVID-19/complications ; COVID-19/virology ; Female ; Humans ; Male ; Polycythemia Vera/pathology ; Polycythemia Vera/virology ; Primary Myelofibrosis/pathology ; Primary Myelofibrosis/virology ; Prognosis ; Thrombocythemia, Essential/pathology ; Thrombocythemia, Essential/virology
Opinia redakcyjna
Tytuł :
Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN).
Autorzy :
Zulkeflee RH; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.; Hospital Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
Zulkafli Z; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.; Hospital Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
Johan MF; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
Husin A; Hospital Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.; Department of Internal Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
Islam MA; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
Hassan R; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.; Hospital Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jul 16; Vol. 18 (14). Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Myeloproliferative Disorders*/epidemiology
Myeloproliferative Disorders*/genetics
Polycythemia Vera*
Calreticulin/genetics ; Humans ; Janus Kinase 2/genetics ; Laboratories ; Malaysia ; Mutation ; Receptors, Thrombopoietin/genetics
Czasopismo naukowe
Tytuł :
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis.
Autorzy :
Jain A; Department of Haematology, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi 110029, India.
Deo P; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sachdeva MUS; Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Bose P; Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lad D; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Prakash G; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Khadwal A; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Varma N; Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Varma S; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Malhotra P; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: .
Pokaż więcej
Źródło :
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2021 Jul; Vol. 89, pp. 102565. Date of Electronic Publication: 2021 Mar 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Cytokines/*blood
Polycythemia Vera/*complications
Thrombosis/*etiology
Adult ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged ; Polycythemia Vera/blood ; Prospective Studies ; Risk Factors ; Thrombosis/blood
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies